Jerome J. Schentag

Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients

Alan Forrest, David E. Nix, Charles H. Ballow et al. · Antimicrobial Agents and Chemotherapy · 1993 · 1.1K citations

Pharmacy, Pharmacokinetics, Pharmacology +16

Relationship of MIC and Bactericidal Activity to Efficacy of Vancomycin for Treatment of Methicillin-Resistant <i>Staphylococcus aureus</i> Bacteremia

George Sakoulas, Pamela A. Moise-Broder, Jerome J. Schentag et al. · Journal of Clinical Microbiology · 2004 · 836 citations · Full text

Life Sciences, Microbiology, Pharmacology +17

Pharmacodynamics of Vancomycin and Other Antimicrobials in Patients with Staphylococcus aureus Lower Respiratory Tract Infections

Pamela A. Moise-Broder, Alan Forrest, Mary C. Birmingham et al. · Clinical Pharmacokinetics · 2004 · 749 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +14

Pharmacodynamic Evaluation of Factors Associated with the Development of Bacterial Resistance in Acutely Ill Patients during Therapy

Jennifer Thomas, Alan Forrest, Sujata M. Bhavnani et al. · Antimicrobial Agents and Chemotherapy · 1998 · 514 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration (T&gt;MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections

Peggy S. McKinnon, Joseph A. Paladino, Jerome J. Schentag · International Journal of Antimicrobial Agents · 2008 · 465 citations

Veterinary Medicine, Infectious Diseases, Microbiology +16